Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01441947
Recruitment Status : Active, not recruiting
First Posted : September 28, 2011
Last Update Posted : April 9, 2018
Information provided by (Responsible Party):
Steven Isakoff, MD, PhD, Massachusetts General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : December 2020